Μετάβαση στο περιεχόμενο

ΕτικέταTeva

GSK’s Nucala Shows Superior Benefits to Other IL-5 Inhibitors in Asthma, But Fails as a COPD Drug

Days after receiving a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on COPD treatment, GlaxoSmithKline released data that showed the same medication was a superior treatment in severe … Continue Reading GSK’s Nucala Shows Superior Benefits to Other IL-5 Inhibitors in Asthma, But Fails as a COPD Drug

Will payers support Amgen’s ‘bolus’ of eager Aimovig patients in time to fend off migraine rivals?

Even though Amgen and Novartis rolled out their hot new migraine drug, Aimovig, at a lower-than-expected price of $6,900, the companies expected pushback from payers, and they prepared for that … Continue Reading Will payers support Amgen’s ‘bolus’ of eager Aimovig patients in time to fend off migraine rivals?